ACE Inhibitors Beneficial in Hypertensive Type 2

4988

Patients with high blood pressure and type 2 diabetes benefit from taking an angiotensin-convertingenzyme (ACE) inhibitor to lower blood pressure—even if they have no evidence of kidney or heart disease.

According to Reuters, Italian researchers studied 1,180 type 2s with hypertension as part of the BENEDICT trial. They found that treatment with the ACE inhibitor trandolapril, combined with another blood-pressure-lowering drug called verapamil (Veratran), delayed the onset of microalbuminuria, which is a build-up of the blood protein albumin in the urine that can signal kidney disease.

* * *

Source: Reuters, Journal of the American Society of Nephrology, December 2006

Comments

comments

This post authored by
Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.